I really can't figure out why PAA can't get any assistance when there are billions of dollars allocated for Covid research by governments and institutions globally.
One thing I know is MPL has remarkable results in the trials and proven safe for human use and there is currently no treatment available and none that could be produced sooner than MPL if required.
Yet here we are and I can't blame investors being frustrated and blaming the management.
Lack of Timeliness and uncertainty is causing the problem.
Management , Share Holder Communications, page-82
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.3¢ |
Change
-0.008(3.75%) |
Mkt cap ! $86.77M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.3¢ | $100.9K | 510.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 431735 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 28192 | 2 |
View Market Depth
| Last trade - 14.40pm 05/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |